Methods and Devices for Improving Mitral Valve Function
    6.
    发明申请
    Methods and Devices for Improving Mitral Valve Function 有权
    改善二尖瓣功能的方法和装置

    公开(公告)号:US20090270980A1

    公开(公告)日:2009-10-29

    申请号:US12498956

    申请日:2009-07-07

    IPC分类号: A61F2/24 A61B8/00

    摘要: The various aspects of the invention pertain to devices and related methods for treating heart conditions, including, for example, dilatation, valve incompetencies, including mitral valve leakage, and other similar heart failure conditions. The devices and related methods of the present invention operate to assist in the apposition of heart valve leaflets to improve valve function. According to one aspect of the invention, a method improves the function of a valve of a heart by placing an elongate member transverse a heart chamber so that each end of the elongate member extends through a wall of the heart, and placing first and second anchoring members external the chamber. The first and second anchoring members are attached to first and second ends of the elongate member to fix the elongate member in a position across the chamber so as to reposition papillary muscles within the chamber. Also described herein is a method for placing a splint assembly transverse a heart chamber by advancing an elongate member through vasculature structure and into the heart chamber.

    摘要翻译: 本发明的各个方面涉及用于治疗心脏病症的装置和相关方法,包括例如扩张,瓣膜无能力,包括二尖瓣渗漏和其它类似的心力衰竭病症。 本发明的装置和相关方法用于协助心脏瓣膜小叶的安置以改善瓣膜功能。 根据本发明的一个方面,一种方法通过将细长构件横向放置在心室中来改善心脏瓣膜的功能,使得细长构件的每个端部延伸穿过心脏的壁,并且将第一和第二锚定 会员外部室。 第一和第二锚固构件附接到细长构件的第一和第二端部,以将细长构件固定在穿过腔室的位置,以便重新定位腔室内的乳头肌肉。 本文还描述了通过使细长构件通过脉管系统结构并进入心脏腔室来放置夹板组件横向于心室的方法。

    Calcification-resistant biomaterials
    7.
    发明授权
    Calcification-resistant biomaterials 失效
    耐钙生物材料

    公开(公告)号:US06302909B1

    公开(公告)日:2001-10-16

    申请号:US08690661

    申请日:1996-07-31

    IPC分类号: A61F202

    摘要: The invention involves a bioprosthetic article including a biocompatible material having at least one bound exogenous storage structure, the storage structures having collectively greater than about 0.5 mg metal cations per gram of biocompatible material. The calcification inhibitors preferably decrease calcium deposition by greater than 95% relative to untreated tissue. The calcification inhibitors are bonded to the bioprosthetic material preferably at a pH between about 6.0 and 8.5.

    摘要翻译: 本发明涉及一种生物假体制品,其包括具有至少一种结合的外源储存结构的生物相容性材料,所述储存结构具有大于约0.5mg金属阳离子/克生物相容性材料。 钙化抑制剂相对于未处理的组织优选减少钙沉积大于95%。 钙化抑制剂优选在约6.0-8.5之间的pH下结合到生物假体材料上。

    Differential treatment of prosthetic devices

    公开(公告)号:US06206917B1

    公开(公告)日:2001-03-27

    申请号:US08850812

    申请日:1997-05-02

    IPC分类号: A61F210

    CPC分类号: A61F2/2415 A61F2/062

    摘要: An apparatus is disclosed for differentially treating a medical device. One portion of the device is treated with a first fluid and a separate portion is treated with a second fluid. The second fluid generally is substantially different from the first fluid. The first fluid can be contacted with an flow region of the medical device. The apparatus can include a conduit system, where fluid flowing through the conduit system flows through the flow region. Sheet material can be treated differentially on the opposite surfaces of the sheet. The medical device can include vascular tissue.

    Endovascular splinting devices and methods
    10.
    发明授权
    Endovascular splinting devices and methods 有权
    血管内夹板装置及方法

    公开(公告)号:US06616684B1

    公开(公告)日:2003-09-09

    申请号:US09679550

    申请日:2000-10-06

    IPC分类号: A61B1708

    摘要: A method for placing a splint assembly transverse a heart chamber includes providing an elongate member having a first end and a second end and a deployable heart-engaging assembly connected to at least the first end. The method includes advancing the elongate member through vasculature structure and into the heart chamber such that the first end of the elongate member extends through a first location of a wall surrounding the heart chamber and the second end extends through a second location of the heart chamber wall substantially opposite the first location. A deployable heart-engaging assembly is deployed such that it engages with a first exterior surface portion of the heart chamber wall adjacent the first location. The elongate member is secured with respect to the heart with a second heart-engaging assembly connected to the second end. The second heart-engaging assembly engages with a second exterior surface portion of the heart chamber wall adjacent the second location. A splint assembly includes an expandable heart-engaging assembly formed partially from portions forming the elongate member of the splint assembly. A delivery tool includes a tubular member configured to be advanced through vasculature structure and has a curved distal end.

    摘要翻译: 用于将夹板组件放置在心室上的方法包括提供具有第一端和第二端的细长构件以及连接到至少第一端的可展开的心脏接合组件。 该方法包括使细长构件通过脉管系统结构推进并进入心室,使得细长构件的第一端延伸穿过围绕心室的壁的第一位置,并且第二端延伸通过心室壁的第二位置 基本上与第一位置相对。 展开的心脏接合组件被布置成使得其与邻近第一位置的心室壁的第一外表面部分接合。 细长构件相对于心脏固定,第二心脏接合组件连接到第二端。 第二心脏接合组件与邻近第二位置的心室壁的第二外表面部分接合。 夹板组件包括可部分地由形成夹板组件的细长构件的部分形成的可膨胀心脏接合组件。 输送工具包括构造成通过脉管系统结构前进并具有弯曲远端的管状构件。